tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VALN Stock Latest News

Valneva and Serum Institute of India Collaborate to Tackle Chikungunya in Asia
Company AnnouncementsValneva and Serum Institute of India Collaborate to Tackle Chikungunya in Asia
1d ago
6K
VALN
Valneva Highlights Chikungunya’s Global Economic Impact
PremiumCompany Announcements
Valneva Highlights Chikungunya’s Global Economic Impact
16d ago
6K
VALN
Valneva’s Chikungunya Vaccine Shows Long-Lasting Efficacy
PremiumCompany Announcements
Valneva’s Chikungunya Vaccine Shows Long-Lasting Efficacy
17d ago
6K
VALN
Valneva Seeks FDA Approval for Expanded Vaccine Use
PremiumCompany Announcements
Valneva Seeks FDA Approval for Expanded Vaccine Use
24d ago
6K
VALN
Valneva submits label extension application for chikungunya vaccine to FDA
PremiumThe Fly
Valneva submits label extension application for chikungunya vaccine to FDA
24d ago
VALN
Valneva Engages Investors with Promising Vaccine Developments
PremiumCompany AnnouncementsValneva Engages Investors with Promising Vaccine Developments
1M ago
6K
VALN
Valneva SE Reports Profitable Nine-Month Performance
Premium
Company Announcements
Valneva SE Reports Profitable Nine-Month Performance
1M ago
VALN
Valneva Reports Profitable Quarter Amid Vaccine Launches
Premium
Company Announcements
Valneva Reports Profitable Quarter Amid Vaccine Launches
1M ago
6K
VALN
Valneva’s Chikungunya Vaccine Gains Scientific Spotlight
PremiumCompany Announcements
Valneva’s Chikungunya Vaccine Gains Scientific Spotlight
2M ago
6K
VALN
Valneva Gains FDA Fast Track for Shigella Vaccine
PremiumCompany Announcements
Valneva Gains FDA Fast Track for Shigella Vaccine
2M ago
6K
VALN
Valneva reports FDA Fast Track Designation for shigella vaccine candidate
PremiumThe Fly
Valneva reports FDA Fast Track Designation for shigella vaccine candidate
2M ago
VALN
Valneva price target lowered to $20 from $23 at H.C. Wainwright
PremiumThe Fly
Valneva price target lowered to $20 from $23 at H.C. Wainwright
2M ago
VALN
Valneva Outlines Future Growth and Vaccine Pipeline
PremiumCompany AnnouncementsValneva Outlines Future Growth and Vaccine Pipeline
2M ago
6K
VALN
Valneva Announces Investor Day to Showcase Vaccine Pipeline
Premium
Company Announcements
Valneva Announces Investor Day to Showcase Vaccine Pipeline
3M ago
6K
VALN
Valneva price target lowered to $23 from $26 at H.C. Wainwright
Premium
The Fly
Valneva price target lowered to $23 from $26 at H.C. Wainwright
3M ago
VALN
Valneva Seeks to Expand Chikungunya Vaccine Use
PremiumCompany Announcements
Valneva Seeks to Expand Chikungunya Vaccine Use
3M ago
6K
VALN
Valneva Launches 60M Euro Share Placement for Vaccine Development
PremiumCompany Announcements
Valneva Launches 60M Euro Share Placement for Vaccine Development
3M ago
6K
VALN
H.C. Wainwright positive on second booster results for VLA15
PremiumThe Fly
H.C. Wainwright positive on second booster results for VLA15
4M ago
PFE
VALN
Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
PremiumThe Fly
Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
4M ago
PFE
VALN
Valneva Advances Lyme Disease Vaccine Candidate
PremiumCompany AnnouncementsValneva Advances Lyme Disease Vaccine Candidate
4M ago
6K
VALN
Valneva Reports Solid H1 2024 Results and Pipeline Growth
Premium
Company Announcements
Valneva Reports Solid H1 2024 Results and Pipeline Growth
4M ago
6K
VALN
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >